Business description – Shalby Limited is one of the leading multi-specialty chain of hospitals in India. Its hospitals are tertiary care hospitals, few of which also offer quaternary healthcare services to patients in various areas of specialisation such as orthopaedics, complex joint replacements, cardiology, neurology, oncology, and renal transplantations. As on the date of this Red Herring Prospectus, it provides inpatient and outpatient healthcare services through 11 operational hospitals with an aggregate bed capacity of 2,012 beds. As on 30 June 2017, the company had nine operational hospitals with an aggregate operational bed count of 841 beds. It had a 15% market share of all joint replacement surgeries conducted by private corporate hospitals in India in 2016. As on the date of this Red Herring Prospectus, the company also provides outpatient services through 47 Outpatient Clinics and has ten shared surgery centres within third party hospitals, which we call Shalby Arthroplasty Centre of Excellence (SACE), where it offers orthopaedic healthcare services including surgeries. Since March 2007, it has conducted an aggregate of 92,100 surgeries, and provided healthcare services to an aggregate of 1,025,533 patients, consisting 133,652 inpatients and 891,881 outpatients.
Headquartered in Ahmedabad, India, it has a domestic and overseas outreach through a network of hospitals in India, and Outpatient Clinics and SACE located in India, Africa, and the Middle East. Having strong presence in western and central India and focus on Tier – I and Tier – II cities, its hospitals operate across five states, Outpatient Clinics operate across 37 cities in 12 states in India, and SACE are present in seven cities in six states in India. Its international footprint consists five Outpatient Clinics and one SACE in Africa, and two SACE in the UAE. The company is expanding footprint in western and central India with hospitals being set up in Nashik and Vadodara.
The Promoters of our Company are Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Shah Family Trust, and Zodiac Mediquip Limited.
Dr Vikram Shah, Dr Darshini Shah, Shanay Shah, Shah Vikram Indrajit HUF and Shah Indrajit Chimanlal HUF are the promoters of Zodiac Mediquip Limited.
Objects of the Issue:
The Offer comprises of the Fresh Issue and the Offer for Sale.
Company proposes to utilise the Net Proceeds from the Fresh Issue towards the following objects:
1. Repayment or prepayment in full, or in part of certain loans availed by the Company;
2. Purchase of medical equipment for existing, recently set up, and upcoming hospitals;
3. Purchase of interiors, furniture, and allied infrastructure for upcoming hospitals; and
4. General corporate purposes.
Company will not receive any proceeds from the Offer for Sale.
»» Issue Open: Dec 5, 2017 – Dec 7, 2017
»» Issue Type: Book Built Issue IPO
»» Issue Size:
› Fresh Issue of [.] Equity Shares of Rs 10 aggregating up to Rs 480.00 Cr
› Offer for Sale of 1,000,000 Equity Shares of Rs 10 aggregating up to Rs [.] Cr
»» Face Value: Rs 10 Per Equity Share
»» Issue Price: Rs 245 – Rs 248 Per Equity Share
»» Market Lot: 60 Shares
»» Minimum Order Quantity: 60 Shares
»» Listing At: BSE, NSE
Please contact us today for application at 033 40266300